Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30-09-2020

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th November, 2020, inter-alia to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2020. This is for your information and record.
04-11-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Certificate Under Regulation 40(10)

 Pursuant to Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that all certificates have been issued, for the half year ended 30th September, 2020, within 30 days of the date of lodgment for This is for your information and record.
17-10-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended September 30, 2020

 Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
15-10-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Half Year Ended 30-09-2020

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the compliance certificate for the half year ended 30th September, 2020. This is for your information and record.
13-10-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 015150 Name of the Signatory :- PRIYA RANJANDesignation :- Company Secretary and Compliance Officer
09-10-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Indraprastha Medical Corporation Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
30-09-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 We wish to inform you that the 32nd Annual General Meeting ('AGM') of the Company was held on 29th September, 2020, through Video Conferencing and Other Audio Visual Means and the business mentioned in the Notice dated 24th August, 2020, was transacted. In this regard, enclosed please find the following- (1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations - Annexure - I; and (2) Consolidated Report of Scrutinizer dated 30th September, 2020, pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014 - Annexure- II. This is for your information and records.
30-09-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit per annexure summary of the proceedings of the 32nd Annual General Meeting of the Company held on 29th September, 2020 through Video Conferencing and Other Audio Visual Means. Kindly take the above information on record.
29-09-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit per annexure summary of the proceedings of the 32nd Annual General Meeting of the Company held on 29th September, 2020 through Video Conferencing and Other Audio Visual Means. Kindly take the above information on record.
29-09-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st October, 2020 till 48 hours after the declaration of financial results for the quarter ending 30th September, 2020. This is for your information and record.
23-09-2020
Next Page
Close

Let's Open Free Demat Account